NIH-funded research P01 program project

Investigating genetic factors affecting cancer risk and outcomes in African Americans

Official title: Genetic Variation in Cancer Risk and Outcomes in African Americans

Funded at Wayne State University · NIH-11034067 · Data updated 2026-11-12

This study is looking at how genetic differences affect cancer risk and outcomes in African American communities, with the goal of finding ways to better prevent and treat cancer for those at higher risk.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionWayne State University
NIH-funded
Lab location1 site (Detroit, United States)
Project startFebruary 13, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$1,860,121
NIH project number5P01CA272239-02
Project IDNIH-11034067 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include African American individuals with a family history of cancer or those diagnosed with multiple primary cancers.

Less likely to help

Patients who do not identify as African American or those without a significant family history of cancer may not benefit from this research.

What this research studies

This research focuses on understanding how genetic variations influence cancer risk and outcomes specifically in African American populations. By analyzing both inherited and acquired genetic mutations, the study aims to identify high-risk individuals and improve cancer prevention and treatment strategies. The project utilizes a large cohort of African American cancer survivors to explore genetic susceptibility and address barriers to genetic testing and counseling. The ultimate goal is to enhance the clinical management of hereditary cancers in this underrepresented group.

Why it matters

Potential benefit: If successful, this research could lead to better cancer prevention strategies and personalized treatment options for African American patients.

How similar studies have gone: Previous research has shown success in identifying genetic factors in cancer risk among diverse populations, but this specific focus on African Americans is relatively novel.

Where this research is happening

  • Wayne State University
    Detroit, United States
    Active

Researchers

  • Principal investigator: Schwartz, Ann G. — Wayne State University
  • Study coordinator: Schwartz, Ann G.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.